Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by francois21on Jan 22, 2015 7:13pm

271 Views

Post# 23353785

RE:Market Cap

PLITheOne, I think you're mistaken the market cap and the shares issued. The market cap is the value of the company using simply the total shares issued ( 547,627,835 ) multiplied by the share price ( $1.71), which give $ 936,443,598.

Bullboard Posts

Gold begins to flow at Endeavour's Lafigué mine in Côte d'Ivoire